Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 17.02 +0.42 (+2.55%)
As of 10:33 AM Eastern

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, MGP, PRTC, and VRP

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Medica Group (MGP), PureTech Health (PRTC), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "medical" sector.

BATM Advanced Communications vs. Its Competitors

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
Tristel 15.47%20.43%9.89%

Tristel has a consensus target price of GBX 400, indicating a potential upside of 10.24%. Given Tristel's stronger consensus rating and higher possible upside, analysts clearly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, BATM Advanced Communications and BATM Advanced Communications both had 1 articles in the media. BATM Advanced Communications' average media sentiment score of 1.35 beat Tristel's score of 0.49 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BATM Advanced Communications
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tristel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£118.82M0.63-£278.26K-£0.06-285.64
Tristel£43.56M3.97£6.54M£0.132,812.79

12.8% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 37.8% of Tristel shares are owned by institutional investors. 23.7% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 21.1% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BATM Advanced Communications has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500.

Summary

Tristel beats BATM Advanced Communications on 10 of the 14 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£74.34M£2.94B£5.77B£2.57B
Dividend Yield3.52%2.05%5.53%5.33%
P/E Ratio-285.64285.5276.435,405.25
Price / Sales0.63100.25535.4197,176.40
Price / Cash2.12146.5437.4627.93
Price / Book0.732.5113.619.12
Net Income-£278.26K£99.80M£3.29B£5.89B
7 Day Performance3.80%1.44%1.67%0.98%
1 Month Performance7.07%1.52%4.05%3.02%
1 Year Performance-14.88%117.27%80.70%199.79%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 17.02
+2.6%
N/A-18.3%£74.34M£118.82M-285.64980Positive News
TSTL
Tristel
0.8693 of 5 stars
GBX 369
+2.5%
GBX 400
+8.4%
-7.1%£176.09M£43.56M2,860.47208Positive News
High Trading Volume
SPEC
INSPECS Group
2.2921 of 5 stars
GBX 42.70
-0.7%
N/A-21.1%£43.41M£198.26M-942.601,673Earnings Report
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3
-3.2%
N/AN/A£7.14M£8.33M428.573,200
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
3.8232 of 5 stars
GBX 235.20
+1.4%
GBX 309.40
+31.5%
+5.2%£4.79B£2.36B2,218.8710,000News Coverage
AMS
Advanced Medical Solutions Group
2.4207 of 5 stars
GBX 207.50
+0.2%
GBX 287.50
+38.6%
-4.9%£448.47M£177.52M6,384.6210Positive News
Earnings Report
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
PRTC
PureTech Health
2.2226 of 5 stars
GBX 107.20
-1.1%
GBX 455
+324.4%
-11.9%£259.09M£6.17M630.59300High Trading Volume
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up

Related Companies and Tools


This page (LON:BVC) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners